2023 was a troublesome calendar year with the biopharma market, with numerous businesses downsizing and restructuring their workforces to remain afloat. You will find indications of recovery, as mergers and acquisitions picked up across the pharmaceutical and daily life sciences field in the latter A part of 2023 and have https://sites.google.com/view/bio-sites/blog